Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Receives FDA Permission to Amend Ongoing Ablatherm-HIFU U.S. Clinical Study Protocol
Broader HIFU Patient Inclusion Criteria Aims to Accelerate Enrollment
View HTML
Toggle Summary EDAP Installs First Ablatherm-HIFU Device in Mexico
Ablatherm Robotic HIFU Receives Approval in Brazil
View HTML
Toggle Summary EDAP Reports Record 2008 Fourth Quarter and Full Year Preliminary Unaudited Revenues
Fourth Quarter 2008 Highlights:, Feb 3, 2009 (GlobeNewswire via COMTEX News Network) -- * Record revenue of EUR 9.0 million, up 29% year-over-year * Ablatherm-HIFU RPP treatments increased 32% year-over-year * Strong EUR 15.0 million (USD 20.8 million) cash position * Robust backlog of
View HTML
Toggle Summary EDAP Installs First Ablatherm-HIFU Device in Second Largest Country World Wide
First Successful Ablatherm Robotic HIFU Treatment in Muljibhai Patel Hospital, India
View HTML
Toggle Summary EDAP Submits 510(k) Filing to U.S. FDA for Sonolith I-Sys
LYON, France, Dec 18, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that it has filed a 510(k) marketing application with the U.S. Food and Drug Administration (FDA) for its newly designed, high-end Sonolith I-Sys
View HTML
Toggle Summary EDAP Highlights Ablatherm-HIFU and Sonolith I-Sys Technologies At French Association of Urology Annual Meeting
LYON, France, Nov 26, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it showcased the Ablatherm-HIFU technology and next generation Sonolith I-Sys device at the French Association of Urology (AFU) Annual
View HTML
Toggle Summary EDAP Reports Third Quarter 2008 Financial Results
Third Quarter 2008 Highlights:, Nov 20, 2008 (GlobeNewswire via COMTEX News Network) -- * Cash position of EUR 14.1 million (USD 19.8 million) supporting growth initiatives * Total HIFU revenue of EUR 1.9 million (USD 2.8 million), up 16.7% sequentially * Gross profit of EUR 2.0 million (USD 2.9
View HTML
Toggle Summary EDAP Announces Webcast and Conference Call of Third Quarter 2008 Results
LYON, France, Oct 30, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2008 earnings announcement, which will take place on Thursday, November 20, 2008, before the opening of
View HTML
Toggle Summary EDAP Features Ablatherm-HIFU and Sonolith I-Sys Devices At Two Prestigious Urological Congresses
LYON, France, Oct 3, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its Ablatherm-HIFU and next generation Sonolith I-Sys devices were highlighted at two major European urological conferences: the 60th
View HTML
Toggle Summary EDAP's Ablatherm-HIFU Technology Featured At City of Hope Second Annual Conference On New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies
LYON, France, Sep 25, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its High Intensity Focused Ultrasound (HIFU) technology was highlighted at the City of Hope Second Annual Conference on New Technologies
View HTML